Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

TSX:ALS - Toronto Stock Exchange - CA0209361009 - Common Stock - Currency: CAD

27.73  +0.68 (+2.51%)

Fundamental Rating

6

Taking everything into account, ALS scores 6 out of 10 in our fundamental rating. ALS was compared to 797 industry peers in the Metals & Mining industry. ALS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALS was profitable.
In the past year ALS had a positive cash flow from operations.
Of the past 5 years ALS 4 years were profitable.
ALS had a positive operating cash flow in each of the past 5 years.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of ALS (14.22%) is better than 94.98% of its industry peers.
ALS has a better Return On Equity (17.89%) than 94.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.54%, ALS belongs to the top of the industry, outperforming 89.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALS is significantly below the industry average of 12.25%.
Industry RankSector Rank
ROA 14.22%
ROE 17.89%
ROIC 2.54%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 179.75%, ALS belongs to the top of the industry, outperforming 99.25% of the companies in the same industry.
In the last couple of years the Profit Margin of ALS has grown nicely.
The Operating Margin of ALS (48.00%) is better than 98.75% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
ALS has a better Gross Margin (88.88%) than 99.75% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 48%
PM (TTM) 179.75%
GM 88.88%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

7

2. Health

2.1 Basic Checks

ALS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALS has less shares outstanding
ALS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALS is higher compared to a year ago.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 5.50 indicates that ALS is not in any danger for bankruptcy at the moment.
ALS has a better Altman-Z score (5.50) than 66.88% of its industry peers.
ALS has a debt to FCF ratio of 4.41. This is a neutral value as ALS would need 4.41 years to pay back of all of its debts.
ALS has a Debt to FCF ratio of 4.41. This is amongst the best in the industry. ALS outperforms 91.22% of its industry peers.
ALS has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.17, ALS is doing worse than 65.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.41
Altman-Z 5.5
ROIC/WACC0.29
WACC8.67%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

ALS has a Current Ratio of 2.91. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
ALS's Current ratio of 2.91 is fine compared to the rest of the industry. ALS outperforms 63.36% of its industry peers.
A Quick Ratio of 2.91 indicates that ALS has no problem at all paying its short term obligations.
The Quick ratio of ALS (2.91) is better than 65.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.91
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.17% over the past year.
Measured over the past years, ALS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.58% on average per year.
The Revenue has decreased by -5.50% in the past year.
The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)4.17%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-9.27%

3.2 Future

Based on estimates for the next years, ALS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.69% on average per year.
ALS is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -21.40% yearly.
EPS Next Y15.96%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
EPS Next 5Y17.69%
Revenue Next Year-6.07%
Revenue Next 2Y2.43%
Revenue Next 3Y5.82%
Revenue Next 5Y-21.4%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 110.92, the valuation of ALS can be described as expensive.
Based on the Price/Earnings ratio, ALS is valued cheaper than 86.07% of the companies in the same industry.
ALS is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 64.75, which means the current valuation is very expensive for ALS.
85.57% of the companies in the same industry are more expensive than ALS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALS to the average of the S&P500 Index (21.76), we can say ALS is valued expensively.
Industry RankSector Rank
PE 110.92
Fwd PE 64.75
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

88.08% of the companies in the same industry are more expensive than ALS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALS is valued cheaper than 91.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 53.76
EV/EBITDA 40.63
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALS does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ALS may justify a higher PE ratio.
A more expensive valuation may be justified as ALS's earnings are expected to grow with 23.48% in the coming years.
PEG (NY)6.95
PEG (5Y)N/A
EPS Next 2Y25.94%
EPS Next 3Y23.48%

6

5. Dividend

5.1 Amount

ALS has a Yearly Dividend Yield of 1.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 13.23, ALS pays a better dividend. On top of this ALS pays more dividend than 96.74% of the companies listed in the same industry.
With a Dividend Yield of 1.33, ALS pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

14.77% of the earnings are spent on dividend by ALS. This is a low number and sustainable payout ratio.
ALS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP14.77%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (7/11/2025, 7:00:00 PM)

27.73

+0.68 (+2.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06
Inst Owners19.64%
Inst Owner ChangeN/A
Ins Owners5.35%
Ins Owner ChangeN/A
Market Cap1.28B
Analysts78.18
Price Target34.17 (23.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP14.77%
Div Incr Years4
Div Non Decr Years4
Ex-Date05-30 2025-05-30 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.23%
Min EPS beat(2)-29.28%
Max EPS beat(2)18.81%
EPS beat(4)1
Avg EPS beat(4)-13.28%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-19.14%
EPS beat(12)2
Avg EPS beat(12)-21.93%
EPS beat(16)3
Avg EPS beat(16)-14.53%
Revenue beat(2)0
Avg Revenue beat(2)-8.45%
Min Revenue beat(2)-11.56%
Max Revenue beat(2)-5.33%
Revenue beat(4)1
Avg Revenue beat(4)-5.19%
Min Revenue beat(4)-15.78%
Max Revenue beat(4)11.92%
Revenue beat(8)2
Avg Revenue beat(8)-8.23%
Revenue beat(12)4
Avg Revenue beat(12)-5.29%
Revenue beat(16)5
Avg Revenue beat(16)-4.14%
PT rev (1m)0.86%
PT rev (3m)5.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.44%
Valuation
Industry RankSector Rank
PE 110.92
Fwd PE 64.75
P/S 22.57
P/FCF 53.76
P/OCF 48.22
P/B 2.25
P/tB 2.25
EV/EBITDA 40.63
EPS(TTM)0.25
EY0.9%
EPS(NY)0.43
Fwd EY1.54%
FCF(TTM)0.52
FCFY1.86%
OCF(TTM)0.58
OCFY2.07%
SpS1.23
BVpS12.34
TBVpS12.34
PEG (NY)6.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.22%
ROE 17.89%
ROCE 3.84%
ROIC 2.54%
ROICexc 2.58%
ROICexgc 2.58%
OM 48%
PM (TTM) 179.75%
GM 88.88%
FCFM 41.99%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexcg growth 3Y-14.71%
ROICexcg growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.41
Debt/EBITDA 2.94
Cap/Depr 47.17%
Cap/Sales 4.83%
Interest Coverage 3.42
Cash Conversion 80.39%
Profit Quality 23.36%
Current Ratio 2.91
Quick Ratio 2.91
Altman-Z 5.5
F-Score5
WACC8.67%
ROIC/WACC0.29
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.17%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-28.57%
EPS Next Y15.96%
EPS Next 2Y25.94%
EPS Next 3Y23.48%
EPS Next 5Y17.69%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-9.27%
Revenue Next Year-6.07%
Revenue Next 2Y2.43%
Revenue Next 3Y5.82%
Revenue Next 5Y-21.4%
EBIT growth 1Y4.92%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year55.21%
EBIT Next 3Y28.31%
EBIT Next 5Y19.49%
FCF growth 1Y-61.2%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-57.69%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%